Alphabiome raised $8M in Seed funding led by AIX Ventures to expand operations and enhance R&D efforts.

May 06, 2025•5 months ago

Amount Raised

$8 Million

Round Type

seed

Tel AvivGeneticsMachine LearningArtificial IntelligenceBiotechnology

Investors

Aix Ventures

Description

Alphabiome, a Tel Aviv-based company, raised $8M in Seed funding to advance technology that extracts genetic biomarkers from microbial DNA. The funding round was led by AIX Ventures and aims to expand operations and R&D. Alphabiome uses a proprietary AI model to decode the human microbiome. They recently conducted a trial identifying over 10,000 complex microbe-derived biomarkers related to drug efficacy.

Company Information

Company

Alphabiome

Location

Tel Aviv, Tel-Aviv District, Israel

About

Alphabiome is a Tel Aviv-based company focused on advancing technology that extracts genetic biomarkers from microbial DNA. It utilizes a proprietary AI model to decode the human microbiome, analyzing vast amounts of genetic data to identify valuable biomarkers for precision medicine. The company combines advanced AI with microbiome analytics, employing innovative mathematical models to uncover previously uncharacterized microbial DNA patterns.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns